Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000913414-09-003772
Filing Date
2009-02-05
Accepted
2009-02-05 13:32:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 nps123108.txt SC 13G 31623
  Complete submission text file 0000913414-09-003772.txt   34012
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Subject) CIK: 0000890465 (see all company filings)

EIN.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-44877 | Film No.: 09571922
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 400 HOWARD STREET SAN FRANCISCO CA 94105
Business Address 400 HOWARD STREET SAN FRANCISCO CA 94105 4155972639
BARCLAYS GLOBAL INVESTORS NA /CA/ (Filed by) CIK: 0000913414 (see all company filings)

EIN.: 943112180 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000